Gama Biotech Farms Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 16-12-2024
- Paid Up Capital ₹ 5.95 M
as on 16-12-2024
- Company Age 11 Year, 14 Days
- Last Filing with ROC 31 Mar 2024
- Revenue 312.86%
(FY 2020)
- Profit 295.05%
(FY 2020)
- Ebitda 180.15%
(FY 2020)
- Net Worth 7.87%
(FY 2020)
- Total Assets -9.62%
(FY 2020)
About Gama Biotech Farms
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 5.95 M, as per Ministry of Corporate Affairs (MCA) records.
Satyanarayana Mantena, Rama Mantena, Anasuya Uppalapati, and One other member serve as directors at the Company.
- CIN/LLPIN
U01403AP2013PTC091656
- Company No.
091656
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Dec 2013
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Company Details
- Location
Krishna, Andhra Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Gama Biotech Farms?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Satyanarayana Mantena  | Managing Director | 12-Dec-2013 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rama Mantena | Director | 03-May-2018 | Current |
| Anasuya Uppalapati | Director | 03-May-2018 | Current |
| Bhargav Mantena | Director | 12-Dec-2013 | Current |
Financial Performance of Gama Biotech Farms.
Gama Biotech Farms Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 312.86% increase. The company also saw a substantial improvement in profitability, with a 295.05% increase in profit. The company's net worth moved up by a moderate rise of 7.87%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gama Biotech Farms?
In 2018, Gama Biotech Farms had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Greenmirror Light Private LimitedActive 11 years 24 daysSatyanarayana Mantena and Bhargav Mantena are mutual person
- Sarvasreshta Agri Private LimitedActive 11 years 24 days
Satyanarayana Mantena and Rama Mantena are mutual person
- Bass Agrivillage India Private LimitedActive 11 years 20 days
Rama Mantena and Bhargav Mantena are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Gama Biotech Farms?
Unlock and access historical data on people associated with Gama Biotech Farms, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gama Biotech Farms, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gama Biotech Farms's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
